Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease

European Respiratory Journal

Volumn 11, Issue 6, 1998, Pages 1329-1336

  Chadelat, K ^a   Boule, M ^a   Corroyer, S ^a   Fauroux, B ^a   Delaisi, B ^a   Tournier, G ^a   Clement, A ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Bronchoalveolar lavage; Children; Insulin like growth factor; Interstitial lung disease

Indexed keywords

MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BRONCHOSCOPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL;

ADOLESCENT; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LUNG DISEASES, INTERSTITIAL; MALE; POLYMERASE CHAIN REACTION; PULMONARY ALVEOLI; RNA, MESSENGER; SOMATOMEDINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031806642     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.11061329     Document Type: Article

References (44)

1. Sara VR, Hall K. Insulin-like growth factors and their binding proteins. Physiol Rev 1990; 70: 591-612.
2. Kelley KM, Oh Y, Gargosky SE, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996; 28: 619-637.
3. Stewart CEH, Rotwen P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996; 76: 1005-1026.
4. D'Ercole AJ. Insulin-like growth factors and their receptors in growth. Endocrinol Metab Clin North Am 1996; 25: 573-590.
5. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995; 16: 3-34.
6. Collett-Solberg PF, Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 1996; 25: 591-614.
7. Stiles AD, D'Ercole AJ. The insulin-like growth factors and the lung. Am J Respir Cell Mol Biol 1990; 3: 93-100.
8. Retsch-Bogart GZ, Moats-Staats BM, Howard K, D'Ercole AJ. Cellular localisation of messenger RNAs for insulin-like growth factors (IGFs), their receptors and binding proteins during fetal rat lung development. Am J Respir Cell Mol Biol 1996; 14: 61-69.
9. Maitre B, Clement A, Williams MC, Brody JS. Expression of insulin-like growth factor receptors 1 and 2 in the developing lung and their relation to epithelial cell differentiation. Am J Respir Cell Mol Biol 1995; 13: 262-270.
10. Moats-Staats BM, Price WA, Xu L, Jarvis W, Stiles AD. Regulation of the insulin-like growth factor system during normal rat lung development. Am J Respir Cell Mol Biol 1995; 12: 56-64.
11. Price WA, Moats-Staats BM, D'Ercole J, Stiies AD. Insulin-like growth factor binding protein production and regulation in fetal rat lung cells. Am J Respir Cell Mol Biol 1993; 8: 425-432.
12. Klempt M, Hutchins AM, Gluckman PD, Skinner SJM. IGF binding protein-2 gene expression and the location of IGF-I and IGF-II in fetal rat lung. Development 1992; 115: 765-772.
13. Lin T, Wang D, Nagpal ML, Chang W, Calkins JH. Down-regulation of leydig cell insulin-like growth factor-I gene expression by interleukin-1. Endocrinology 1992; 130: 1217-1224.
14. McAnulty RJ, Guerreiro D, Cambrey AD, Laurent GJ. Growth factor activity in the lung during compensatory growth after pneumonectomy evidence of a role for IGF-1. Eur Respir J 1992; 5: 739-747.
15. Yateman ME, Claffey DC, Hughes SC, Frost VJ, Wass JAH, Holly JMP. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 1993; 137: 151-159.
16. Aston C, Jagirdar J, Lee TC, Hur T, Hintz RL, Rom WN. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 151: 1597-1603.
17. Homma S, Nagaoka I, Abe H, et al. Localisation of platelet-derived growth factor and insulin-like growth factor-I in the fibrotic lung. Am J Respir Crit Care Med 1995; 152: 2084-2089.
18. Pierce GF. Macrophages: important physiologic and pathologic sources of polypeptides growth factors. Am J Respir Cell Mol Biol 1990; 2: 233-243.
19. Lohmann-Matthes M-L, Steinmuller C, Franke-Ullmann GF. Pulmonary macrophages. Eur Respir J 1994; 7: 1678-1689.
20. Tessier V, Chadelat K, Baculard A, Housset B, Clement A. BAL in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis. Chest 1996; 109: 1430-1438.
21. Bokulic R, Hilman B. Interstitial lung disease in children. Pediatr Clin North Am 1994; 41: 543-567.
22. Chadelat K, Baculard A, Tournier G, Boule M, Boccon-Gibod L, Clement A. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatement. Pediatr Pulmonol 1993; 16: 41-47.
23. Clement A, Campisi J, Farmer SR, Brody JS. Constitutive expression of growth-related mRNAs in proliferating and nonproliferating lung epithelial cells in primary culture: evidence for growth-dependent translational control. Proc Natl Acad Sci USA 1990; 87: 318-322.
24. Adolff CH, Golden JA, Kennedy PW, Goetzi EJ, Turck CW. Polymerase chain reaction amplification of messages for growth factors in cells from human bronchoalveolar lavage fluids. Inflammation 1991; 15: 259-268.
25. Rappolee DA, Wang A, Mark D, Werb Z. Novel method for studying mRNA phenotypes in single or small numbers of cells. J Cell Biochem 1989; 39: 1-11.
26. Irminger J-C, Rosen KM, Humbel RE, Villa-Komaroff L. Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5′ untranslated regions. Proc Natl Acad Sci USA 1987; 84: 6330-6334.
27. Binkert C, Landwehr J, Mary J-L, Schwander J, Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J 1989; 8: 2497-2502.
28. Cubbage ML, Suwanichkul A, Powell DR. Insulin-like growth factor binding protein-3. J Biol Chem 1990; 265: 12642-12649.
29. Taylor IK, Sorooshian M, Wangoo A, et al. Platelet-derived growth factor-β mRNA in human alveolar macrophages in vivo in asthma. Eur Respir J 1994; 7: 1966-1972.
30. Mouhieddine B, Cazals V, Maitre B, Chadelat K, Le Bouc Y, Clement A. Insulin-like growth factor II (IGF-II), type 2 IGF receptor and IGF-binding protein-2 gene expression in lung alveolar epithelial cells: relation to proliferation. Endocrinology 1994; 135: 83-91.
31. Jones JL, Gockerman A, Busby WH, Wright G, Clemmons DR. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 1993; 90: 10553-10557.
32. Muller-Quernheim J, Pfeifer S, Mannel D, Strausz J, Ferlinz R. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 1992; 145: 187-192.
33. Rom WN. Human mononuclear phagocytes express the insulin-like growth factor-II/mannose-6-phosphate receptor. Am J Respir Cell Mol Biol 1991; 4: 555-559.
34. Nyman T, Pekonen F. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol 1993; 128: 168-172.
35. Cassatella MA. The production of cytokines by polymor-phonuclear neutrophils. Immunol Today 1995; 16: 21-26.
36. Lake FR, Noble PW, Henson PM, Riches DWH. Functional switching of macrophages responses to tumor necrosis factor-α (TNFα) by interferons. J Clin Invest 1994; 93: 1661-1669.
37. Arkins S, Rebeiz N, Brunke-Reese DL, Biragyn A, Kelley KW. Interferon-γ inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol Endocrinol 1995; 9: 350-360.
38. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982; 125: 740-745.
39. Castranova V, Rabovsky J, Tucker JH, Miles PR. The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol Appl Pharmacol 1988; 93: 472-483.
40. Adamson IYR. Bowden DH. Type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamic study in mice after exposure to oxygen. Lab Invest 1974; 30: 35-42.
41. Cazals V, Mouhiedine B, Maitre B, et al. Insulin-like growth factors, their binding proteins and transforming growth factor-beta 1 in oxidant arrested lung alveolar epithelial cells. J Biol Chem 1994; 269: 14111-14117.
42. Mouhieddine OB, Cazals V, Kuto E, Le Bouc Y, Clement A. Glucocorticoid-induced growth arrest of lung alveolar epithelial cells is associated with increased production of insulin like growth factor binding protein-2. Endocrinology 1996; 137: 287-295.
43. Goldstein S, Moerman EJ, Jones RA, Baxter RC. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts. Proc Natl Acad Sci USA 1991; 88: 9680-9684.
44. Oh Y, Muller HL, Ng L, Rosenfeld RG. Transforming growth factor-β induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995; 270: 13589-13592.